Education
About Us
Working with TipRanks
Follow Us
Concord Medical Services (CCM)
NYSE:CCM
RESEARCH TOOLSreports
Total Valuation
Concord Medical Services has a market cap or net worth of $31.17M. The enterprise value is $1.04B.
Market Cap$31.17M
Enterprise Value$1.04B
Share Statistics
Concord Medical Services has 2,815,458 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,815,458
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Concord Medical Services’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is -9.31%.
Return on Equity (ROE)0.14
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-9.31%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee903.20K
Profits Per Employee-500.27K
Employee Count595
Asset Turnover0.09
Inventory Turnover15.22
Valuation Ratios
The current PE Ratio of Concord Medical Services is -1.20. Concord Medical Services’s PEG ratio is 0.03.
PE Ratio-1.20
PS Ratio0.00
PB Ratio-0.17
Price to Fair Value-0.17
Price to FCF-0.91
Price to Operating Cash Flow-1.29
PEG Ratio0.03
Income Statement
In the last 12 months, Concord Medical Services had revenue of 537.40M and earned -297.66M in profits. Earnings per share was -2.27.
Revenue537.40M
Gross Profit-76.61M
Operating Income-462.99M
Pretax Income-555.59M
Net Income-297.66M
EBITDA-344.16M
Earnings Per Share (EPS)-2.27
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Concord Medical Services pays an annual dividend of $9.8, resulting in a dividend yield of ―
Dividend Per Share$9.8
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change39.00%
50-Day Moving Average4.95
200-Day Moving Average5.66
Relative Strength Index (RSI)66.86
Average Volume (3m)48.45K
Important Dates
Concord Medical Services upcoming earnings date is Sep 27, 2024, TBA Not Confirmed.
Last Earnings DateSep 22, 2023
Next Earnings DateSep 27, 2024
Ex-Dividend DateDec 23, 2015
Financial Position
Concord Medical Services as a current ratio of 0.32, with Debt / Equity ratio of -166.65%
Current Ratio0.32
Quick Ratio0.30
Debt to Market Cap8.57
Net Debt to EBITDA-9.41
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Concord Medical Services has paid 24.57M in taxes.
Income Tax24.57M
Effective Tax Rate-0.04
Enterprise Valuation
Concord Medical Services EV to EBITDA ratio is -40.49, with an EV/FCF ratio of -35.53.
EV to Sales25.93
EV to EBITDA-40.49
EV to Free Cash Flow-35.53
EV to Operating Cash Flow-50.40
Balance Sheet
Concord Medical Services has $326.90M in cash and marketable securities with ― in debt, giving a net cash position of $3.24B billion.
Cash & Marketable Securities$326.90M
Total Debt―
Net Cash$3.24B
Net Cash Per Share$1.15K
Tangible Book Value Per Share$6.47
Margins
Gross margin is -17.72%, with operating margin of -86.15%, and net profit margin of -55.39%.
Gross Margin-17.72%
Operating Margin-86.15%
Pretax Margin-103.39%
Net Profit Margin-55.39%
EBITDA Margin-64.04%
EBIT Margin-86.15%
Analyst Forecast
The average price target for Concord Medical Services is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-29.82%
EPS Growth Forecast-2.57%